TrialBritish journal of cancer2025

Prompt initiation of durvalumab and tremelimumab for unresectable hepatocellular carcinoma in patients with chronic active hepatitis B: a phase 2 clinical trial.

Yu-Yun Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.